Styl cytowania APA

de Jesús, S., Sadyrbaeva, S., Hidalgo-Tenorio, C., Jiménez-Morales, A., & Pasquau, J. (2018). 4CPS-069 Economic impact of off-label use of dalbavancin for treatment of infectious endocarditis and bloodstream infections caused by grampositive bacteria. Eur J Hosp Pharm.

Styl cytowania Chicago

de Jesús, S., S. Sadyrbaeva, C. Hidalgo-Tenorio, A. Jiménez-Morales, i J. Pasquau. "4CPS-069 Economic Impact of Off-label Use of Dalbavancin for Treatment of Infectious Endocarditis and Bloodstream Infections Caused By Grampositive Bacteria." Eur J Hosp Pharm 2018.

Styl cytowania MLA

de Jesús, S., et al. "4CPS-069 Economic Impact of Off-label Use of Dalbavancin for Treatment of Infectious Endocarditis and Bloodstream Infections Caused By Grampositive Bacteria." Eur J Hosp Pharm 2018.

Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..